AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER
What Are Doctors Saying About Cancer Prevention? Insights from Leading Oncologists
By The Cancer News Team
Leading oncologists discuss evidence-based cancer prevention strategies, treatment-related weight gain, and major gaps in survivorship care, based on insights shared at a major oncology conference.
What Are Doctors Saying About Cancer Prevention? Insights from Leading Oncologists
By The Cancer News Team
Leading oncologists discuss evidence-based cancer prevention strategies, treatment-related weight gain, and major gaps in survivorship care, based on insights shared at a major oncology conference.
What Are Doctors Saying About Cancer Prevention? Insights from Leading Oncologists
By The Cancer News Team
Leading oncologists discuss evidence-based cancer prevention strategies, treatment-related weight gain, and major gaps in survivorship care, based on insights shared at a major oncology conference.
Dr. Bart L Scott on Treatment Approaches in Newly Diagnosed Acute Myeloid Leukemia
By The Cancer News Team
Summary of Dr. Bart L. Scott’s presentation on first-line treatment strategies for newly diagnosed acute myeloid leukemia, highlighting azacitidine–venetoclax, the Paradigm trial, and patient-centered decision-making.
Dr. Bart L Scott on Treatment Approaches in Newly Diagnosed Acute Myeloid Leukemia
By The Cancer News Team
Summary of Dr. Bart L. Scott’s presentation on first-line treatment strategies for newly diagnosed acute myeloid leukemia, highlighting azacitidine–venetoclax, the Paradigm trial, and patient-centered decision-making.
Dr. Bart L Scott on Treatment Approaches in Newly Diagnosed Acute Myeloid Leukemia
By The Cancer News Team
Summary of Dr. Bart L. Scott’s presentation on first-line treatment strategies for newly diagnosed acute myeloid leukemia, highlighting azacitidine–venetoclax, the Paradigm trial, and patient-centered decision-making.
How Medical Oncologists Select Targeted Therapies for Breast Cancer ESR1 and Pancreatic MTAP Mutations
By The Cancer News Team
Expert tumor board discussion from the Precision Oncology Summit on ESR1-mutant breast cancer and MTAP-deleted pancreatic cancer, highlighting real-world cases, oral SERDs, PRMT5 inhibitors, and biomarker-driven treatment decisions.
How Medical Oncologists Select Targeted Therapies for Breast Cancer ESR1 and Pancreatic MTAP Mutations
By The Cancer News Team
Expert tumor board discussion from the Precision Oncology Summit on ESR1-mutant breast cancer and MTAP-deleted pancreatic cancer, highlighting real-world cases, oral SERDs, PRMT5 inhibitors, and biomarker-driven treatment decisions.
How Medical Oncologists Select Targeted Therapies for Breast Cancer ESR1 and Pancreatic MTAP Mutations
By The Cancer News Team
Expert tumor board discussion from the Precision Oncology Summit on ESR1-mutant breast cancer and MTAP-deleted pancreatic cancer, highlighting real-world cases, oral SERDs, PRMT5 inhibitors, and biomarker-driven treatment decisions.
New Study Offers Hope for Better Treatment Strategies: Understanding Blast Phase Chronic Myeloid Leukemia
By Akriti Jain, MD
A leukemia specialist discusses new insights from a multicenter U.S. study on blast phase chronic myeloid leukemia, highlighting treatment patterns, outcomes, and the critical role of TKIs and transplantation.
New Study Offers Hope for Better Treatment Strategies: Understanding Blast Phase Chronic Myeloid Leukemia
By Akriti Jain, MD
A leukemia specialist discusses new insights from a multicenter U.S. study on blast phase chronic myeloid leukemia, highlighting treatment patterns, outcomes, and the critical role of TKIs and transplantation.
New Study Offers Hope for Better Treatment Strategies: Understanding Blast Phase Chronic Myeloid Leukemia
By Akriti Jain, MD
A leukemia specialist discusses new insights from a multicenter U.S. study on blast phase chronic myeloid leukemia, highlighting treatment patterns, outcomes, and the critical role of TKIs and transplantation.
Caution about Ivermectin for Cancer Treatment from an Oncologist
By Dr. Binay Shah
An oncologist cautions against the use of ivermectin for cancer treatment, explaining why preliminary lab studies and online misinformation do not replace evidence-based clinical trials.
Caution about Ivermectin for Cancer Treatment from an Oncologist
By Dr. Binay Shah
An oncologist cautions against the use of ivermectin for cancer treatment, explaining why preliminary lab studies and online misinformation do not replace evidence-based clinical trials.
Caution about Ivermectin for Cancer Treatment from an Oncologist
By Dr. Binay Shah
An oncologist cautions against the use of ivermectin for cancer treatment, explaining why preliminary lab studies and online misinformation do not replace evidence-based clinical trials.
Artificial Intelligence Transforming Precision Medicine: From Genetic Discovery to Patient Monitoring
By The Cancer News Team
Artificial intelligence is transforming precision medicine by enabling genetic discovery, continuous patient monitoring, personalized diabetes care, and advanced medical imaging to improve cancer outcomes.
Artificial Intelligence Transforming Precision Medicine: From Genetic Discovery to Patient Monitoring
By The Cancer News Team
Artificial intelligence is transforming precision medicine by enabling genetic discovery, continuous patient monitoring, personalized diabetes care, and advanced medical imaging to improve cancer outcomes.
Artificial Intelligence Transforming Precision Medicine: From Genetic Discovery to Patient Monitoring
By The Cancer News Team
Artificial intelligence is transforming precision medicine by enabling genetic discovery, continuous patient monitoring, personalized diabetes care, and advanced medical imaging to improve cancer outcomes.
What Types of Cancer Cause Low Hemoglobin?
By Chandra Lalita Kakarala, MD
An expert overview of how different cancers cause low hemoglobin, explaining anemia mechanisms, symptoms, diagnosis, and treatment in cancer patients.
What Types of Cancer Cause Low Hemoglobin?
By Chandra Lalita Kakarala, MD
An expert overview of how different cancers cause low hemoglobin, explaining anemia mechanisms, symptoms, diagnosis, and treatment in cancer patients.
What Types of Cancer Cause Low Hemoglobin?
By Chandra Lalita Kakarala, MD
An expert overview of how different cancers cause low hemoglobin, explaining anemia mechanisms, symptoms, diagnosis, and treatment in cancer patients.
2025 Oncology Year in Review: Breakthrough Cancer Treatments and Research
By Aishat Motolani, PhD
A comprehensive 2025 oncology year in review exploring breakthroughs in cancer treatment, AI in oncology, immunotherapy approvals, liquid biopsy debates, mRNA vaccines, and global cancer health equity.
2025 Oncology Year in Review: Breakthrough Cancer Treatments and Research
By Aishat Motolani, PhD
A comprehensive 2025 oncology year in review exploring breakthroughs in cancer treatment, AI in oncology, immunotherapy approvals, liquid biopsy debates, mRNA vaccines, and global cancer health equity.
2025 Oncology Year in Review: Breakthrough Cancer Treatments and Research
By Aishat Motolani, PhD
A comprehensive 2025 oncology year in review exploring breakthroughs in cancer treatment, AI in oncology, immunotherapy approvals, liquid biopsy debates, mRNA vaccines, and global cancer health equity.
San Antonio Breast Cancer Symposium 2025: Oncologist's Review of Key Trial Results and Therapeutic Advances
By Dr. Milana Dolezal
An oncologist’s expert review of pivotal clinical trials and therapeutic advances in early and metastatic breast cancer presented at the San Antonio Breast Cancer Symposium 2025.
San Antonio Breast Cancer Symposium 2025: Oncologist's Review of Key Trial Results and Therapeutic Advances
By Dr. Milana Dolezal
An oncologist’s expert review of pivotal clinical trials and therapeutic advances in early and metastatic breast cancer presented at the San Antonio Breast Cancer Symposium 2025.
San Antonio Breast Cancer Symposium 2025: Oncologist's Review of Key Trial Results and Therapeutic Advances
By Dr. Milana Dolezal
An oncologist’s expert review of pivotal clinical trials and therapeutic advances in early and metastatic breast cancer presented at the San Antonio Breast Cancer Symposium 2025.
ASH 2025 Highlights: Top Hematology Research Abstracts, Selected by Field Experts
By The Cancer News Team
A curated expert review of the most impactful leukemia and myeloproliferative neoplasm (MPN) research abstracts presented at the 2025 American Society of Hematology (ASH) Annual Meeting.
ASH 2025 Highlights: Top Hematology Research Abstracts, Selected by Field Experts
By The Cancer News Team
A curated expert review of the most impactful leukemia and myeloproliferative neoplasm (MPN) research abstracts presented at the 2025 American Society of Hematology (ASH) Annual Meeting.
ASH 2025 Highlights: Top Hematology Research Abstracts, Selected by Field Experts
By The Cancer News Team
A curated expert review of the most impactful leukemia and myeloproliferative neoplasm (MPN) research abstracts presented at the 2025 American Society of Hematology (ASH) Annual Meeting.